NovoMix 30 FlexPen 100 IU/mL – 5 × 3 mL

NovoMix 30 FlexPen 100 IU/mL is a pre-filled insulin pen containing biphasic insulin aspart, a premixed insulin used to help control blood glucose levels in people with diabetes mellitus. Each FlexPen contains 3 mL (300 units), and the pack contains 5 pre-filled pens.

Product Details

• Brand: NovoMix 30 FlexPen
• Generic Name: Biphasic Insulin Aspart
• Strength: 100 IU/mL
• Dosage Form: Suspension for injection
• Pack Size: 5 pre-filled FlexPens × 3 mL
• Total Volume: 15 mL
• Total Insulin: 1,500 units per pack
• Manufacturer: Novo Nordisk
• Route of Administration: Subcutaneous injection
• Composition: 30% soluble insulin aspart + 70% protamine-crystallised insulin aspart

What Is NovoMix 30 Used For?

NovoMix 30 is used to improve blood glucose control in patients with diabetes mellitus. It contains both a faster-acting and an intermediate-acting component, providing insulin coverage around meals as well as between meals. It is indicated for adults and can also be used in appropriate younger patients according to medical advice.

How NovoMix 30 Works

NovoMix 30 combines:

• 30% soluble insulin aspart – the more rapidly acting component.
• 70% protamine-crystallised insulin aspart – the longer/intermediate-acting component.

Together, these components help lower elevated blood glucose and provide coverage over a longer period than rapid-acting insulin alone.

Dosage and Administration

The dose of NovoMix 30 is individualized by the doctor according to blood glucose levels, diet, physical activity, other diabetes medicines, and insulin requirements. Blood glucose monitoring is recommended, particularly when starting or changing insulin treatment.

NovoMix 30 is administered under the skin (subcutaneously). Do not change the number of insulin units or injection schedule without consulting your doctor.

Important: Resuspension Before Injection

NovoMix 30 is a cloudy suspension, not a clear insulin solution. The FlexPen must be properly resuspended according to the manufacturer's instructions before each injection. It should appear uniformly white and cloudy after proper mixing. Do not use it if the appearance remains abnormal.

Common Side Effects

Possible side effects include:

• Hypoglycemia (low blood sugar)
• Injection-site reactions
• Redness, swelling or itching at the injection site
• Weight gain
• Allergic reactions
• Changes in vision associated with changes in blood-glucose control

Low blood sugar is an especially important risk with insulin therapy.

Symptoms of Low Blood Sugar

Hypoglycemia may cause:

• Sweating
• Shaking
• Hunger
• Dizziness
• Headache
• Fast heartbeat
• Confusion
• Weakness

Severe hypoglycemia can result in loss of consciousness and requires urgent medical treatment.

Important Precautions

Tell your doctor if you have kidney or liver disease, because insulin requirements may change. Extra monitoring may also be needed when changing from another insulin preparation.

Do not share your FlexPen with another person, even if the needle has been changed.

Drug Interactions

Some medicines can increase or decrease the blood-glucose-lowering effect of insulin. Inform your doctor about all medicines you take, including:

• Other diabetes medicines
• Beta-blockers
• Corticosteroids
• Certain blood-pressure medicines
• Medicines affecting blood glucose
• Herbal products and supplements

Storage

Unopened NovoMix 30 FlexPens should generally be stored in a refrigerator at 2–8°C and must not be frozen. Protect them from light and excessive heat.

A FlexPen that is currently being used or carried as a spare can generally be kept at below 30°C for up to 4 weeks, according to the product information.

NovoMix 30 FlexPen in Pakistan

NovoMix 30 FlexPen 100 IU/mL, 5 × 3 mL is listed by Pakistani pharmacies and medicine suppliers. Current online listings show that availability and prices can vary considerably between pharmacies, so customers should confirm stock, cold-chain handling, batch number, and expiry date before purchase.

Important Note

NovoMix 30 is a prescription insulin and should be used according to the individual insulin regimen prescribed by a healthcare professional. Never adjust the dose yourself based only on a single blood glucose reading.

Disclaimer: This description is for educational and product-information purposes and does not replace advice from a doctor or pharmacist.